AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 FEB 20 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Using a combination of cytokine-based gene therapy and tumor cell vaccination, medical investigators have been able to produce immunity against brain tumors in rats.
The strategy of using a combination of therapies attempts to overcome previous problems seen in gene therapies meant for treating brain tumors, for it addresses the need for antigen presentation as well as sufficient immune cell recruitment, according to Y. Iwadate and associates at Chiba University Graduate School of Medicine in Japan.
"We investigated the therapeutic potential of induced systemic immunity in peripheral tissues combined with interleukin (IL-2) production in the vicinity of brain tumors to treat established brain tumors," described Iwadate and coworkers in Cancer Research.
To do that, researchers injected rodents intracerebrally with rat glioma cells (9L) that produced IL-2 (9L/IL-2) and subcutaneously with either irradiated 9L glioma cells or 9L/IL-2. Rats already growing 9L tumors were cured when treated with the combination therapy but not when they were treated with either the cytokine or vaccine therapies alone.
"Xenogeneic murine neuroblastoma cells secreting IL-2 could substitute for 9L/IL-2 cells, producing significant antitumor effects in the vaccinated rats," researchers said.
Investigators also observed more tumor-specific cytotoxic activity in dual-treated animals, and immune response ...
Source: HighBeam Research, Vaccine Combination Rejects Brain Tumor Establishment In...